China Pharma Inc. (CPHI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

China Pharma Inc.

AMEX: CPHI · Real-Time Price · USD
1.78
0.10 (6.27%)
At close: Sep 08, 2025, 3:59 PM
1.80
1.17%
After-hours: Sep 08, 2025, 05:14 PM EDT

China Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
4.53M 7.01M 8.1M 9.64M
Cost of Revenue
6.51M 7.29M 8.6M 9.29M
Gross Profit
-1.99M -281.08K -493.92K 349.27K
Operating Income
-4.59M -2.75M -3.55M -3.12M
Interest Income
6.64K 6.6K 10.76K 3.04K
Pretax Income
-4.74M -3.08M -3.97M -3.4M
Net Income
-4.74M -3.08M -10.22M -3.94M
Selling & General & Admin
2.31M 2.25M 2.96M 3.15M
Research & Development
283.94K 240.08K 185.86K 318.96K
Other Expenses
5.7K -15.76K 93.85K n/a
Operating Expenses
2.6M 2.47M 3.15M 3.46M
Interest Expense
154.14K 333.6K 434.62K 542K
Selling & Marketing Expenses
528.82K 780.33K 1.07M 1.5M
Cost & Expenses
9.12M 9.76M 5.54M 12.76M
Income Tax Expense
n/a n/a 6.25M 542K
Shares Outstanding (Basic)
17.46M 10.6M 5.26M 4.61M
Shares Outstanding (Diluted)
17.46M 10.6M 5.26M 4.61M
EPS (Basic)
-0.27 -0.29 -1.94 -0.85
EPS (Diluted)
-0.27 -0.29 -1.94 -0.85
EBITDA
-1.96M 8.44K -837.69K 230.34K
EBIT
-4.58M -2.75M -3.54M -2.86M
Depreciation & Amortization
2.62M 2.75M 2.7M 3.09M